2016 (11 POSTS)

Sacks NC, Noone J, Cyr PL, Miller DJ, Chiarella MT, Louie AC. Hospitalizations for older patients with acute myeloid leukemia (AML): High costs and long stays, with and without chemotherapy. Academy Health Annual Research Meetings, Boston, MA, 2016.

Jensen IS, Wu C, Fan W, Lodise T, Nicolau, DP, DuFour S, Cyr PL, et al. 2016. Use of oritivancin in moderate-severe ABSSSI patients requiring IV antibiotics: US hospital budget impact analysis. J Manag Care Spec Pharm 22(6):752-64; doi: 10.18553/jmcp.2016.22.6.752.

View Abstract

Jensen IS, Lodise TP, Fan W, Wu C, Cyr PL, Nicolau DP, DuFour S, et al. 2016. Use of oritavancin in acute bacterial skin and skin structure infection patients receiving intravenous antibiotics: A US hospital budget impact analysis. Clin Drug Investig. 2016 36(2):157-68; doi: 10.1007/s40261-015-0365-8.

View Abstract

Sacks NC, Cyr P, Liu Y, Miller DJ, Chiarella MT, Louie AC. 2016. Burden of acute myeloid leukemia (AML) among older newly-diagnosed patients. Blood 128(22):4780; doi: 10.1182/blood.V128.22.4780.4780.

View Abstract

Sacks NC, Noone J, Cyr PL, Miller DJ, Chiarella MT, Louie AC. 2016. Hospitalizations for older patients with acute myeloid leukemia (AML): Inpatient treatment is intensive and costly. Value in Health 19(3):A246; doi: 10.1016/j.jval.2016.03.1051.

View Abstract

Sacks NC, Sharma A, Cyr PL, Liu Y, Miller DJ, Chiarella MT, Louie AC. 2016. Outcomes for older patients with acute myeloid leukemia (AML): Multiple hospitalizations and high mortality rates. Value in Health 19(7):A611; doi: 10.1016/j.jval.2016.09.1523.

View Abstract

Meddings J, Kuhn L, Reichert H. Indwelling urinary catheter awareness, order, and indications in ICUs. Presented at the Society for Healthcare Epidemiology of America (SHEA) Annual Meeting, Atlanta, GA, May 2016.

Meddings J, Reichert H, Smith SN, McMahon LF Jr. How do hospital grades publicly displayed on Medicare’s Hospital Compare website compare to whether a hospital was penalized for readmissions and hospital-acquired conditions? Presented at the Society of General Internal Medicine (SGIM) 2016 Annual Meeting, Hollywood, FL, May 2016.

Sacks NC, Cabral HJ, Pizer SD, Burgess JF. 2016. Myopic and forward looking behavior in branded oral anti-diabetic consumption: An example from Medicare Part D. Health Econ 26(6):753-764; doi: 10.1002/hec.3355. PMID: 27150938.

View Abstract

2015 (9 POSTS)

Sacks NC, Ash AS, Ghosh K, Rosen AK, Wong JB, Rosen AB. 2015. Trends in acute myocardial infarction hospitalizations: Are we seeing the whole picture? Am Heart J 170(6):1211-19; doi: 10.1016/j.ahj.2015.09.009. PMID: 26678643.

View Abstract

Meddings J, Reichert H, Smith S, Iwashyna T, Langa K, Hofer T, McGuirk H, McMahon LF Jr. Functional status, social support and wealth impact readmissions for pneumonia and heart failure beyond standard Medicare risk-adjustors. Presented at the 11th International Conference on Health Policy Statistics, Providence, RI, October 2015

Meddings J, Reichert H, Smith SN, McMahon LF Jr. How do hospital grades publicly displayed on Medicare’s Hospital Compare website compare to whether a hospital was penalized for readmissions and hospital-acquired conditions? Presented at the 2015 Agency for Heathcare Research and Quality (AHRQ) Research Conference, Crystal City, VA, October 4-6, 2015.

Sacks NC, Ash AS, Ghosh K, Rosen AK, Wong JB, Cutler DM, Rosen AB. 2015. Recent national trends in acute myocardial infarction hospitalizations in Medicare: Shrinking declines and growing disparities [Letter to the Editor]. Epidemiol 26(4):e46–47; doi: 10.1097/EDE.0000000000000298. PMID: 25924109.

View Abstract

Wu E, Jensen IS, Cyr PL, Fan W, Mitchell M, Sulham K, Nathwani D. Use of oritavancin for the treatment of skin and soft tissue infections: A UK hospital budget impact analysis. ISPOR 20th Annual International Meeting, Philadelphia, PA, 2015.

Jensen I, Halbert R, Giuseppe R, Naoshy S, Iqbal SU, Zhimin X, McSweeney P. 2015. A hospital budget impact model to evaluate plerixafor in stem cell mobilization: Impact of primary research and direct stakeholder engagement. Eur J Hosp Pharm 22(3):142–149; doi: 10.1136/ejhpharm-2014-000543.

View Abstract

Meddings J, Reichert H, Smith S, Iwashyna T, Langa K, Hofer T, McGuirk H, McMahon LF Jr. Functional status, social support and wealth impact readmissions for pneumonia and heart failure beyond standard Medicare risk-adjustors. Academy Health Annual Research Meeting, June 14-15, 2015, Minneapolis, MN.

Sacks NC, Burgess JF, Cabral HJ, McDonnell ME, Pizer SD. 2015. The effects of cost sharing on adherence to medications prescribed for concurrent use: Do definitions matter? J Manag Care Pharmacy 21(8):678–687.

View Abstract

Doucette A, Jiang X, Fryzek J, Coalson J, McLaurin K, Ambrose CS. Comparison of trends in bronchiolitis and respiratory syncytial virus infant hospitalizations rates in 3 US nationally representative databases. Presented at the Pediatric Academic Societies Annual Meeting, San Diego, CA, April 2015.

2014 (10 POSTS)

Wu C, Fortier KJ, LaPensee K, Fan W, Mitchell M, Cyr PL, Jensen IS. A US hospital economic impact model for oritavancin in ABSSSI patients with risk of MRSA infections. Abstract PSS10, ISPOR 17th Annual European Congress 2014.

View Abstract

Jensen IS, Bay C, Cyr PL. Estimating the impact of combining cangrelor and bivalirudin to a U.S. hospital performing PCI procedures. ISPOR 18th Annual International Meeting, New Montreal Quebec, 2014.